See The Comparison
The short version
Choose Conveo when the value is in hearing real people - their voice, their hesitation, their words on video - and you can wait hours or days for fieldwork. Choose BluePill when you need to narrow a wide field quickly, test packs and claims against a competitive set, and re-run the same audience as the design changes.
Conveo | BluePill | |
|---|---|---|
Who answers | Real recruited participants, interviewed by an AI moderator | Simulated twins built from in-depth interviews with real category buyers |
Method | Asynchronous video, voice and text interviews at scale | Simulated response to a stimulus, quant and open-ended |
Time to result | Hours to days, depending on recruitment and fielding | Minutes |
Recruitment | Required - screening, incentives, scheduling | None |
Best output | Real verbatims, video clips, emotional nuance | Rankings, drivers, diagnostics and verbatims across an audience |
Iteration | Each revision means fielding again | Re-run instantly on a revised pack or claim |
Category depth | Method-led and category-agnostic | Built around CPG - food and beverage, beauty, wellness, healthcare |
Best for | Depth interviews where the human record matters | Fast comparative testing of packs, claims and concepts |
The honest framing is not speed versus depth. It is whether your next decision needs a real person on the record, or needs twelve options narrowed to three by Thursday.
Where the two genuinely differ
Conveo's proposition is that an AI moderator can conduct a proper semi-structured interview - listening, probing, following the thread - with a real human on the other end, and do it a thousand times in parallel. That removes the scheduling bottleneck that has always capped qualitative research, and it produces something BluePill cannot: an actual person saying an actual thing, on video, that you can put in a deck.
BluePill removes the human from the loop entirely. Twins are built from in-depth interviews with real category buyers, then simulated, which means no recruitment, no incidence problem, and no waiting. The trade is that you are working with a model of an audience rather than the audience itself, which is why we validate against parallel human panels and publish the correlation per study.
In practice, teams using both put Conveo where the human record matters - a launch narrative, a stakeholder-facing film, an unfamiliar audience - and BluePill where the question is comparative and the option count is high.
One thing worth correcting
Comparisons in this category often describe AI interview platforms as survey tools with self-report bias and weeks of lag. That is not accurate for Conveo. They do not run surveys, they run interviews, their turnaround is hours to days rather than weeks, and reducing social desirability bias is part of their pitch rather than a weakness of it. If a comparison page tells you otherwise, it was written without reading their product.
When Conveo is the better choice
You need real people on the record. Video clips, attributable quotes, a human voice for a stakeholder audience.
The category is genuinely new. With no behavioural precedent to ground twins in, simulation has nothing to learn from and real interviews do.
Emotional nuance is the finding. Hesitation, tone and body language carry information no simulation reproduces.
The output has to stand up externally. Claim substantiation and regulatory work need real respondents.
You are running exploratory discovery. Open-ended understanding of a space you have not researched before.
When BluePill is the better choice
And several where we would tell you the opposite.
You are narrowing, not exploring. Twelve concepts to three, twenty claims to five, before anyone spends fieldwork money.
The stimulus keeps changing. Re-running a revised pack against the same audience costs nothing and takes minutes.
You need competitive-set context. Shelf comparison against the specific SKUs you sit beside is built in.
Incidence is the problem. Low-incidence audiences drive recruitment cost sharply; simulated audiences are not constrained by it.
You have more questions than budget. The tests that never justified fieldwork become affordable.
AI Consumer Digital Twins
Synthetic agents built on historical behavioral data, not just LLM prompts.
Not "AI Surveys"
We don't ask AI to fill out forms; we place them in a virtual market environment.
Validated Accuracy
Results are back-tested against real world sales and high-quality human panels.
Does Conveo use synthetic respondents?
No. Conveo interviews real recruited participants using an AI moderator. The AI is the interviewer, not the respondent, and that is the fundamental difference between the two platforms.
Can BluePill give me video clips or quotes from real people?
No. BluePill returns open-ended responses in the language real category buyers use, because each twin is grounded in an interview with one - but it cannot give you a real person on video saying it. If the deliverable is a highlight reel or an attributable quote, that is what Conveo is for.
Does Conveo run surveys?
No. Conveo runs AI-moderated video and voice interviews, not surveys, and its turnaround is hours to days rather than weeks. Comparisons describing it as a survey tool with self-report bias and weeks of lag were written without reading the product - reducing social desirability bias is part of Conveo's own pitch.
Do I need to recruit participants for BluePill?
No. There is no screening, no incentives and no scheduling. That also means low-incidence audiences - category rejecters, specific conditions, senior buyers - are not the cost problem they are in recruited research.
Which is better for early concept screening?
BluePill, when you are narrowing many options and the design is still moving. Conveo, when you are exploring an unfamiliar space and need to hear how real people talk about it before you have concepts to screen.
How we made this comparison
Everything on this page about Conveo is drawn from Conveo's own public materials, with each claim linked to its source. AI research platforms change quickly, so this page carries a review date and we check it quarterly. BluePill figures come from studies validated against parallel live human panels. If we have described something incorrectly, get in touch and we will fix it.
Last reviewed: